United States - English - NLM (National Library of Medicine)

mission pharmacal company - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), ferrous gluconate (unii: u1b11i423z) (ferrous cation - unii:gw89581owr), iron pentacarbonyl (unii: 6wq62taq6z) (ferrous cation - unii:gw89581owr), docusate sodium (unii: f05q2t2ja0) (docusate - unii:m7p27195ag) - ascorbic acid 120 mg - citranatal bloom dha is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

Australia - English - Department of Health (Therapeutic Goods Administration)

phytologic holdings pty limited - ascorbic acid, quantity: 40 mg; silicon dioxide, quantity: 20 mg; vitis vinifera, quantity: 100 mg (equivalent: vitis vinifera, qty 12000 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; purified water; silicon dioxide; sorbitol; hypromellose; magnesium stearate - antioxidant/reduce free radicals formed in the body ; maintain/support collagen formation ; maintain/support general health and wellbeing ; maintain/support nail health/strength/thickness ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; maintain/support bone health ; aids/assists healthy bone development/growth/building ; help maintain/support bone mineralisation ; helps maintain/supports healthy joint cartilage growth/development/production ; maintain/support blood capillary health ; maintain/support blood vessel health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support tendon health ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support skin health ; maintain/support skin integrity/structure

Australia - English - Department of Health (Therapeutic Goods Administration)

sunshine australia enterprises pty ltd - ascorbic acid, quantity: 40 mg; vitis vinifera, quantity: 100 mg (equivalent: vitis vinifera, qty 12 g); demineralised fish proteoglycan extract, quantity: 105 mg - capsule, soft - excipient ingredients: iron oxide black; yellow beeswax; purified water; iron oxide red; soya oil; lecithin; hydrogenated vegetable oil; d-alpha-tocopherol; gelatin; glycerol; squalene; hydrolysed collagen - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support skin health ; maintain/support skin elasticity ; maintain/support skin integrity/structure

Australia - English - Department of Health (Therapeutic Goods Administration)

bomax pty ltd - sodium ascorbate, quantity: 340 mg; ascorbic acid, quantity: 200 mg - tablet, chewable - excipient ingredients: sucralose; acesulfame potassium; citric acid monohydrate; magnesium stearate; sunset yellow fcf aluminium lake; isomalt; sorbitol; flavour - nutritional function - vitamin c is necessary to facilitate iron absorption - vitamin c is an antioxidant, or free radical scavenger and therefore helps to prevent free radical damage. - vitamin c is necessary for desmoplasia and to maintain connective tissue function.

Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - ascorbic acid, quantity: 60 mg; calcium citrate, quantity: 300 mg (equivalent: calcium, qty 63.2 mg); zinc amino acid chelate, quantity: 12.5 mg (equivalent: zinc, qty 2.5 mg); calcium phosphate, quantity: 325 mg (equivalent: calcium, qty 126 mg); folic acid, quantity: 100 microgram; magnesium phosphate pentahydrate, quantity: 65 mg (equivalent: magnesium, qty 13.4 mg); manganese amino acid chelate, quantity: 15 mg (equivalent: manganese, qty 1.5 mg); phytomenadione, quantity: 5 microgram; heavy magnesium oxide, quantity: 170 mg (equivalent: magnesium, qty 102.5 mg); calcium amino acid chelate, quantity: 200 mg (equivalent: calcium, qty 40 mg); colecalciferol, quantity: 0.005 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; purified talc; titanium dioxide; colloidal anhydrous silica; macrogol 8000; tapioca starch; hypromellose; sodium starch glycollate; magnesium stearate; carnauba wax; calcium hydrogen phosphate dihydrate; maize starch; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil - maintain/support general health and wellbeing ; maintain/support bone health ; maintain/support (state mineral) absorption in bones ; maintain/support bone strength ; help maintain/support bone mineralisation ; a diet deficient in calcium can lead to osteoporosis in later life. calcium may help prevent osteoporosis when dietary intake is inadequate ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; maintain/support muscle function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support nervous system function

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - ascorbic acid, quantity: 4.7 g; sodium chloride, quantity: 2.691 g; sodium sulfate, quantity: 7.5 g; potassium chloride, quantity: 1.015 g; macrogol 3350, quantity: 100 g; sodium ascorbate, quantity: 5.9 g - powder - excipient ingredients: acesulfame potassium; aspartame; flavour - for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g. bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - cyanocobalamin, quantity: 1.25 microgram; biotin, quantity: 25 microgram; pyridoxine hydrochloride, quantity: 1.34 mg (equivalent: pyridoxine, qty 1.1 mg); ascorbic acid, quantity: 40 mg; potassium iodide, quantity: 65.4 microgram (equivalent: iodine, qty 50 microgram); monobasic potassium phosphate, quantity: 29.3 mg (equivalent: potassium, qty 8.4 mg); calcium phosphate, quantity: 19.38 mg (equivalent: calcium, qty 7.5 mg); ferrous fumarate, quantity: 1.52 mg (equivalent: iron, qty 500 microgram); chromic chloride hexahydrate, quantity: 38.4 microgram (equivalent: chromium, qty 7.5 microgram); zinc sulfate monohydrate, quantity: 4.12 mg (equivalent: zinc, qty 1.5 mg); nicotinamide, quantity: 8 mg; colecalciferol, quantity: 0.0025 mg; dl-alpha-tocopheryl acetate, quantity: 8.94 mg - pastille - excipient ingredients: gelatin; glycerol; purified water; sucrose; ascorbic acid; liquid glucose; malic acid; carnauba wax; vegetable oil; flavour; maize starch; acacia; potable water; calcium phosphate; dl-alpha-tocopherol; fractionated coconut oil; colour; hypromellose; sorbitol; medium chain triglycerides; pectin; starch sodium octenyl succinate; silicon dioxide - antioxidant/reduce free radicals formed in the body ; maintain/support collagen formation ; maintain/support collagen health ; maintain/support energy levels ; helps convert (state food) into energy ; maintain/support energy production ; maintain/support vitality ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; maintain/support hair health ; maintain/support healthy teeth ; aid/assist nail growth ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; maintain/support body tissue repair/regeneration ; helps enhance/promote body tissue repair/regeneration ; helps enhance/promote bone health ; maintain/support bone health ; aids/assists healthy bone development/growth/building ; helps enhance/promote bone mass/density ; maintain/support (state mineral) absorption in bones ; maintain/support bone strength ; help maintain/support bone mineralisation ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; aid/assist healthy red blood cell production ; maintain/support blood health ; maintain/support healthy cardiovascular system function ; maintain/support heart health ; aid/assist thyroid hormone production ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support healthy muscle contraction function ; maintain/support muscle health ; maintain/support muscle function ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; helps decrease/reduce homocysteine levels ; helps enhance/promote/increase absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system health ; maintain/support nervous system function ; maintain/support reproductive system health ; maintain/support healthy reproductive hormones ; maintain/support skin health

United States - English - NLM (National Library of Medicine)

flon laboratories llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febril states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid

United States - English - NLM (National Library of Medicine)

raw materials international overseas llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - simvastatin, quantity: 40 mg; ezetimibe, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; butylated hydroxyanisole; hypromellose; iron oxide black; microcrystalline cellulose; propyl gallate; ascorbic acid; iron oxide yellow; croscarmellose sodium; citric acid; magnesium stearate; iron oxide red - adults (?18 years),prevention of cardiovascular disease apo-ezetimibe/simvastatin is indicated in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs) taking their maximum tolerated dose of simvastatin and in need of additional lowering of ldl-c in the expectation of a modest further reduction in the risk of cardiovascular events following at least one year of therapy (see clinical trials).,primary hypercholesterolaemia apo-ezetimibe/simvastatin is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate: ? patients not appropriately controlled with a statin or ezetimibe alone. ? patients already treated with a statin and ezetimibe.,homozygous familial hypercholesterolaemia (hofh) apo-ezetimibe/simvastatin is indicated in patients with hofh. patients may also receive adjunctive treatments (e.g., ldl apheresis). children and adolescents 10-17 years (pubertal status: boys tanner stage ii and above and girls who are at least one year post- menarche),heterozygous familial hypercholesterolaemia (hefh) apo-ezetimibe/simvastatin is indicated as adjunctive therapy to diet in adolescent patients (10-17 years old) with heterozygous familial hypercholesterolaemia where use of a combination product is appropriate: ? patients not appropriately controlled with a statin or ezetimibe alone. ? patients already treated with a statin and ezetimibe.,homozygous familial hypercholesterolaemia (hofh) apo-ezetimibe/simvastatin is indicated in adolescent patients (10-17 years old) with hofh. patients may also receive adjunctive treatments (e.g., ldl apheresis).